Cargando…
Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy
As the coronavirus disease 2019 (COVID-19) pandemic is evolving, coagulopathy induced by the disease and its severe complications are raising concerns in the medical community. Because coagulopathy caused by COVID-19 has been difficult to control, it is important to have a better understanding of wh...
Autor principal: | Turshudzhyan, Alla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294862/ https://www.ncbi.nlm.nih.gov/pubmed/32550069 http://dx.doi.org/10.7759/cureus.8150 |
Ejemplares similares
-
Uremic and Post-Transplant Gastropathy in Patients With Chronic Kidney Disease and End-Stage Renal Disease
por: Turshudzhyan, Alla, et al.
Publicado: (2020) -
Common Coagulopathies Associated With COVID-19 Patients
por: Gupta, Vinish, et al.
Publicado: (2023) -
Acute Limb Ischemia in COVID-19 Disease: A Mysterious Coagulopathy
por: Anwar, Shamsuddin, et al.
Publicado: (2020) -
Coronavirus Disease 2019-Induced Rhabdomyolysis
por: Meegada, Sreenath, et al.
Publicado: (2020) -
Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)